Arthur C. Houts
Affiliations: | The University of Memphis, Memphis, TN, United States |
Area:
Clinical Psychology, OncologyGoogle:
"Arthur Houts"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Houts AC, Olufade T, Shenolikar R, et al. (2019) Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings. Cancer Treatment and Research Communications. 19: 100121 |
| Houts A, Olufade T, Shenolikar R, et al. (2018) Abstract P4-09-15: Real-world clinical outcomes in BRCA-positive metastatic breast cancer patients treated in the community oncology setting Cancer Research. 78 |
| Houts AC, Ogale S, Sommer N, et al. (2017) Treatment Patterns and Outcomes in Patients with KRAS Wild-Type Metastatic Colorectal Cancer Treated in First Line with Bevacizumab- or Cetuximab-Containing Regimens. Journal of Gastrointestinal Cancer |
| Houts AC, Ogale S, Zafar Y, et al. (2017) Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings. Journal of Gastrointestinal Cancer |
| Walker MS, Pohl GM, Houts AC, et al. (2016) Analysis of the psychological impact of cancer-related symptoms on patients with non-small cell lung cancer. Psycho-Oncology |
| Houts AC, Ogale S, Sommer N, et al. (2016) Treatment patterns and outcomes in patients with KRAS wild type (WT) metastatic colorectal cancer (mCRC) treated in first line with bevacizumab (B) or cetuximab (C) containing regimens. Journal of Clinical Oncology. 34: 550-550 |
| Walker MS, Cong Z, Knopf KB, et al. (2015) Real world impact of treatment-induced peripheral neuropathy (TIPN) on patient reported outcomes (PROs) in patients with multiple myeloma (MM) in the United States. Journal of Clinical Oncology. 33 |
| Walker MS, Masaquel AS, Kerr J, et al. (2014) Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden. Breast Cancer Research and Treatment. 144: 673-81 |
| Monberg MJ, Houts AC, Walker MS, et al. (2014) Observational study of treatment patterns among patients initiating first-line treatment for chronic lymphocytic leukemia in the U.S. community oncology setting. Journal of Clinical Oncology. 32 |
| Freiden Y, Thul A, Houts AC. (2013) Reduction in chemotherapy administered at the end of life (CAEOL) through quality improvement processes in a large community oncology clinic: The West Clinic experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 159 |